Ibrutinib Therapy Releases Leukemic Surface IgM From Antigen Drive in Chronic Lymphocytic Leukemia Patients.
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-1286
Full Text
Open PDFAbstract
Available in full text
Date
October 29, 2018
Authors
Publisher
American Association for Cancer Research (AACR)